These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 25005704

  • 1. Is there still a role for abatacept in the treatment of lupus?
    Hoi A, Littlejohn G.
    Expert Opin Biol Ther; 2014 Sep; 14(9):1345-50. PubMed ID: 25005704
    [Abstract] [Full Text] [Related]

  • 2. Biologics in SLE: towards new approaches.
    van Vollenhoven RF, Parodis I, Levitsky A.
    Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):341-9. PubMed ID: 24238691
    [Abstract] [Full Text] [Related]

  • 3. [What's new in internal medicine: emerging treatments for systemic lupus erythematosus].
    Hachulla É.
    Ann Dermatol Venereol; 2011 Dec; 138 Suppl 4():S241-4. PubMed ID: 22202645
    [Abstract] [Full Text] [Related]

  • 4. Abatacept for systemic lupus erythematosus: the outlook.
    Mok CC.
    Expert Opin Biol Ther; 2012 Dec; 12(12):1559-61. PubMed ID: 22946545
    [Abstract] [Full Text] [Related]

  • 5. Abatacept in the treatment of lupus.
    Hoi AY, Littlejohn GO.
    Expert Opin Biol Ther; 2012 Oct; 12(10):1399-406. PubMed ID: 22870890
    [Abstract] [Full Text] [Related]

  • 6. Abatacept for the treatment of systemic lupus erythematosus.
    Pimentel-Quiroz VR, Ugarte-Gil MF, Alarcón GS.
    Expert Opin Investig Drugs; 2016 Oct; 25(4):493-9. PubMed ID: 26878310
    [Abstract] [Full Text] [Related]

  • 7. [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part II. Tocilizumab, Abatacept, Rituximab--drugs characterised by a different mechanism of action than TNF-alpha inhibitors].
    Swierkot J, Madej M.
    Pol Merkur Lekarski; 2011 Apr; 30(178):289-94. PubMed ID: 21595177
    [Abstract] [Full Text] [Related]

  • 8. When biologics should be used in systemic lupus erythematosus?
    Gottenberg JE, Lorenzo N, Sordet C, Theulin A, Chatelus E, Sibilia J.
    Presse Med; 2014 Jun; 43(6 Pt 2):e181-5. PubMed ID: 24933678
    [Abstract] [Full Text] [Related]

  • 9. New biologic therapy for systemic lupus erythematosus.
    Ding HJ, Gordon C.
    Curr Opin Pharmacol; 2013 Jun; 13(3):405-12. PubMed ID: 23664092
    [Abstract] [Full Text] [Related]

  • 10. [The management of systemic lupus erythematosus with biological therapies].
    Malaise O, von Frenckell C, André B, Malaise MG.
    Rev Med Suisse; 2013 Aug 28; 9(395):1507-11. PubMed ID: 24024419
    [Abstract] [Full Text] [Related]

  • 11. How to treat refractory arthritis in lupus?
    Artifoni M, Puéchal X.
    Joint Bone Spine; 2012 Jul 28; 79(4):347-50. PubMed ID: 22341583
    [Abstract] [Full Text] [Related]

  • 12. Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies.
    Favalli EG, Biggioggero M, Marchesoni A, Meroni PL.
    Rheumatology (Oxford); 2014 Sep 28; 53(9):1664-8. PubMed ID: 24729445
    [Abstract] [Full Text] [Related]

  • 13. Update on the use of biologics in lupus.
    Relan M, Vishwanath S, Shen L, Ambrus JL.
    Curr Pharm Biotechnol; 2014 Sep 28; 15(6):516-20. PubMed ID: 25091119
    [Abstract] [Full Text] [Related]

  • 14. Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.
    Dall'era M, Chakravarty EF.
    Curr Rheumatol Rep; 2011 Aug 28; 13(4):308-16. PubMed ID: 21584692
    [Abstract] [Full Text] [Related]

  • 15. Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis.
    Maneiro RJ, Salgado E, Carmona L, Gomez-Reino JJ.
    Semin Arthritis Rheum; 2013 Aug 28; 43(1):9-17. PubMed ID: 23290690
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness simulation model of biologic strategies for treating to target rheumatoid arthritis in Germany.
    Beresniak A, Baerwald C, Zeidler H, Krüger K, Neubauer AS, Dupont D, Merkesdal S.
    Clin Exp Rheumatol; 2013 Aug 28; 31(3):400-8. PubMed ID: 23464803
    [Abstract] [Full Text] [Related]

  • 17. Systemic lupus erythematosus: an update on current pharmacotherapy and future directions.
    Touma Z, Urowitz MB, Gladman DD.
    Expert Opin Biol Ther; 2013 May 28; 13(5):723-37. PubMed ID: 23339281
    [Abstract] [Full Text] [Related]

  • 18. Rituximab - shadow, illusion or light?
    van Vollenhoven RF.
    Autoimmun Rev; 2012 Jun 28; 11(8):563-7. PubMed ID: 22036829
    [Abstract] [Full Text] [Related]

  • 19. Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases.
    Ramos-Casals M, Soto MJ, Cuadrado MJ, Khamashta MA.
    Lupus; 2009 Aug 28; 18(9):767-76. PubMed ID: 19578100
    [Abstract] [Full Text] [Related]

  • 20. Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies.
    Fattah Z, Isenberg DA.
    Expert Opin Biol Ther; 2014 Mar 28; 14(3):311-26. PubMed ID: 24387632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.